Healthcare Industry In Malaysia 2019

The total healthcare industry spending in malaysia which stood at rm52 billion at end 2017 is expected to reach about rm80 billion by 2020 fuelled by increasing demand for healthcare services and emergence of new care models beyond traditional hospital settings according to business consulting firm frost sullivan.

Healthcare industry in malaysia 2019. Dec 31 2019 usd 1 995. Information and analysis on the healthcare. Malaysia as one of asia s most recognized developing countries has risen to its immense potential as a preferred healthcare travel destination for the world. Our 2020 malaysia report include trends statistics.

The recently announced 2019 malaysian budget proposed an increase in public healthcare expenditure with the government pushing forward with fundamental healthcare initiatives. Shah alam march 1. For malaysia next year is also malaysia year of healthcaretravel 2020 myht launched in conjunction with the national visit malaysia 2020 campaign. Malaysia healthcare industry report 2015.

Healthcare regulatory and reimbursement landscape malaysia. In a report by fitch solutions government investment will support the future growth of the pharmaceutical and healthcare industry in malaysia. Healthcare in malaysia is an attractive proposition offering world class quality healthcare which is easily accessible and competitively affordable for patients peace of mind. Region wise asia is seen as the new centre of growth for healthcare as many economies have a relatively underdeveloped healthcare system.

While growth prospects for the sector globally are positive in the long term underpinned by an ageing population rising affluence and increasing life. Malaysia with a score of 95 out of 100 ranked first in the best healthcare in the world category of the 2019 international living annual global retirement index. The healthcare and industrial sectors are glowing in johor s iskandar malaysia despite the challenging market environment thanks mainly to strong interest from foreign investors.